KEVZARA (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the KEVZARA drug offered from sanofi-aventis U.S. LLC. This Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | sarilumab |
| SUBSTANCE NAME: | SARILUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-05-22 |
| END MARKETING DATE: | 0000-00-00 |
KEVZARA HUMAN PRESCRIPTION DRUG Details:
| Item Description | KEVZARA from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1.14mL) |
| START MARKETING DATE: | 2017-05-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5908_322dfe38-b3af-4520-8e38-b45d992ea7c1 |
| PRODUCT NDC: | 0024-5908 |
| APPLICATION NUMBER: | BLA761037 |
Other SARILUMAB Pharmaceutical Manufacturers / Labelers:
